These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 26775837)

  • 1. Verbal memory and 5-HT1A receptors in healthy volunteers--A PET study with [carbonyl-(11)C]WAY-100635.
    Penttilä J; Hirvonen J; Tuominen L; Lumme V; Ilonen T; Någren K; Hietala J
    Eur Neuropsychopharmacol; 2016 Mar; 26(3):570-7. PubMed ID: 26775837
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lateralization of the serotonin-1A receptor distribution in language areas revealed by PET.
    Fink M; Wadsak W; Savli M; Stein P; Moser U; Hahn A; Mien LK; Kletter K; Mitterhauser M; Kasper S; Lanzenberger R
    Neuroimage; 2009 Apr; 45(2):598-605. PubMed ID: 19103294
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuroticism and serotonin 5-HT1A receptors in healthy subjects.
    Hirvonen J; Tuominen L; Någren K; Hietala J
    Psychiatry Res; 2015 Oct; 234(1):1-6. PubMed ID: 26337006
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serotonin 5-HT1A receptor binding potential declines with age as measured by [11C]WAY-100635 and PET.
    Tauscher J; Verhoeff NP; Christensen BK; Hussey D; Meyer JH; Kecojevic A; Javanmard M; Kasper S; Kapur S
    Neuropsychopharmacology; 2001 May; 24(5):522-30. PubMed ID: 11282252
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Altered brain serotonin 5-HT1A receptor binding after recovery from anorexia nervosa measured by positron emission tomography and [carbonyl11C]WAY-100635.
    Bailer UF; Frank GK; Henry SE; Price JC; Meltzer CC; Weissfeld L; Mathis CA; Drevets WC; Wagner A; Hoge J; Ziolko SK; McConaha CW; Kaye WH
    Arch Gen Psychiatry; 2005 Sep; 62(9):1032-41. PubMed ID: 16143735
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative analyses of carbonyl-carbon-11-WAY-100635 binding to central 5-hydroxytryptamine-1A receptors in man.
    Farde L; Ito H; Swahn CG; Pike VW; Halldin C
    J Nucl Med; 1998 Nov; 39(11):1965-71. PubMed ID: 9829590
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterisation of the appearance of radioactive metabolites in monkey and human plasma from the 5-HT1A receptor radioligand, [carbonyl-11C]WAY-100635--explanation of high signal contrast in PET and an aid to biomathematical modelling.
    Osman S; Lundkvist C; Pike VW; Halldin C; McCarron JA; Swahn CG; Farde L; Ginovart N; Luthra SK; Gunn RN; Bench CJ; Sargent PA; Grasby PM
    Nucl Med Biol; 1998 Apr; 25(3):215-23. PubMed ID: 9620626
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Parametric and regional maps of free serotonin 5HT1A receptor sites in human brain as function of age in healthy humans.
    Møller M; Jakobsen S; Gjedde A
    Neuropsychopharmacology; 2007 Aug; 32(8):1707-14. PubMed ID: 17251909
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo occupancy of the 5-HT1A receptor by a novel pan 5-HT1(A/B/D) receptor antagonist, GSK588045, using positron emission tomography.
    Comley RA; van der Aart J; Gulyás B; Garnier M; Iavarone L; Halldin C; Rabiner EA
    Neuropharmacology; 2015 May; 92():44-8. PubMed ID: 25476970
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantification of serotonin 5-HT1A receptors in monkey brain with [11C](R)-(-)-RWAY.
    Yasuno F; Zoghbi SS; McCarron JA; Hong J; Ichise M; Brown AK; Gladding RL; Bacher JD; Pike VW; Innis RB
    Synapse; 2006 Dec; 60(7):510-20. PubMed ID: 16952161
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative assessment of (18) F-Mefway as a serotonin 5-HT1A receptor PET imaging agent across species: Rodents, nonhuman primates, and humans.
    Mukherjee J; Bajwa AK; Wooten DW; Hillmer AT; Pan ML; Pandey SK; Saigal N; Christian BT
    J Comp Neurol; 2016 May; 524(7):1457-71. PubMed ID: 26509362
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 5-HT1A gene promoter polymorphism and [18F]MPPF binding potential in healthy subjects: a PET study.
    Lothe A; Boni C; Costes N; Bouvard S; Gorwood P; Lavenne F; Alvarez M; Ryvlin P
    Behav Brain Funct; 2010 Jul; 6():37. PubMed ID: 20609217
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Measurement of serotonin 5-HT1A receptor binding using positron emission tomography and [carbonyl-(11)C]WAY-100635-considerations on the validity of cerebellum as a reference region.
    Hirvonen J; Kajander J; Allonen T; Oikonen V; Någren K; Hietala J
    J Cereb Blood Flow Metab; 2007 Jan; 27(1):185-95. PubMed ID: 16685258
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A positron emission tomography study to assess binding of lecozotan, a novel 5-hydroxytryptamine-1A silent antagonist, to brain 5-HT1A receptors in healthy young and elderly subjects, and in patients with Alzheimer's disease.
    Raje S; Patat AA; Parks V; Schechter L; Plotka A; Paul J; Langstrom B
    Clin Pharmacol Ther; 2008 Jan; 83(1):86-96. PubMed ID: 17507923
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantification of the Serotonin 1A Receptor Using PET: Identification of a Potential Biomarker of Major Depression in Males.
    Kaufman J; Sullivan GM; Yang J; Ogden RT; Miller JM; Oquendo MA; Mann JJ; Parsey RV; DeLorenzo C
    Neuropsychopharmacology; 2015 Jun; 40(7):1692-9. PubMed ID: 25578798
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Central serotonin 1A receptor binding in temporal lobe epilepsy: a [carbonyl-(11)C]WAY-100635 PET study.
    Assem-Hilger E; Lanzenberger R; Savli M; Wadsak W; Mitterhauser M; Mien LK; Stögmann E; Baumgartner C; Kletter K; Asenbaum S
    Epilepsy Behav; 2010 Nov; 19(3):467-73. PubMed ID: 20850389
    [TBL] [Abstract][Full Text] [Related]  

  • 17. First-in-human evaluation of 18F-mefway, a PET radioligand specific to serotonin-1A receptors.
    Hillmer AT; Wooten DW; Bajwa AK; Higgins AT; Lao PJ; Betthauser TJ; Barnhart TE; Rowley HA; Stone CK; Johnson SC; Mukherjee J; Christian BT
    J Nucl Med; 2014 Dec; 55(12):1973-9. PubMed ID: 25453045
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo relationship between serotonin 1A receptor binding and gray matter volume in the healthy brain and in major depressive disorder.
    Zanderigo F; Pantazatos S; Rubin-Falcone H; Ogden RT; Chhetry BT; Sullivan G; Oquendo M; Miller JM; Mann JJ
    Brain Struct Funct; 2018 Jul; 223(6):2609-2625. PubMed ID: 29550938
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [carbonyl-11C]Desmethyl-WAY-100635 (DWAY) is a potent and selective radioligand for central 5-HT1A receptors in vitro and in vivo.
    Pike VW; Halldin C; McCarron JA; Lundkvist C; Hirani E; Olsson H; Hume SP; Karlsson P; Osman S; Swahn CG; Hall H; Wikström H; Mensonidas M; Poole KG; Farde L
    Eur J Nucl Med; 1998 Apr; 25(4):338-46. PubMed ID: 9553162
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decreased brain serotonin 5-HT1A receptor availability in medication-naive patients with major depressive disorder: an in-vivo imaging study using PET and [carbonyl-11C]WAY-100635.
    Hirvonen J; Karlsson H; Kajander J; Lepola A; Markkula J; Rasi-Hakala H; Någren K; Salminen JK; Hietala J
    Int J Neuropsychopharmacol; 2008 Jun; 11(4):465-76. PubMed ID: 17971260
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.